Effect of systemic hypertension with vs without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey)
The American Journal of Cardiology May 19, 2018
Erkuner O, et al. - Whether hypertension-induced left ventricular hypertrophy (LVH) confers risk for both progression of atrial fibrillation (AF) and development of AF-related complications, i.e. major adverse cardiac and cerebrovascular events (MACCE), was determined in low-risk AF patients (patients from the Euro Heart Survey with non-valvular AF and a baseline echocardiogram, with and without hypertension). Gender-associated disparities were also addressed. Multivariable logistic regression revealed LVH to be the most important multi-variably adjusted determinant of AF progression amongst hypertensive AF patients. No differences were seen in MACCE for hypertensive patients with and without LVH. Overall, LVH was found to be related to AF progression in hypertensive males. No such link seemed to exist in hypertensive women.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries